Ultragenyx Pharmaceutical Inc (RARE)
42.61
+1.49
(+3.62%)
USD |
NASDAQ |
May 16, 16:00
42.60
-0.01
(-0.02%)
Pre-Market: 20:00
Ultragenyx Pharmaceutical Price to Book Value: 25.25 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 25.25 |
| May 15, 2024 | 24.37 |
| May 14, 2024 | 24.28 |
| May 13, 2024 | 24.28 |
| May 10, 2024 | 24.24 |
| May 09, 2024 | 24.43 |
| May 08, 2024 | 24.63 |
| May 07, 2024 | 24.87 |
| May 06, 2024 | 25.49 |
| May 03, 2024 | 25.34 |
| May 02, 2024 | 25.60 |
| May 01, 2024 | 25.66 |
| April 30, 2024 | 25.21 |
| April 29, 2024 | 26.09 |
| April 26, 2024 | 26.22 |
| April 25, 2024 | 25.99 |
| April 24, 2024 | 26.24 |
| April 23, 2024 | 26.74 |
| April 22, 2024 | 25.89 |
| April 19, 2024 | 25.10 |
| April 18, 2024 | 25.70 |
| April 17, 2024 | 26.13 |
| April 16, 2024 | 25.07 |
| April 15, 2024 | 25.40 |
| April 12, 2024 | 27.85 |
| Date | Value |
|---|---|
| April 11, 2024 | 30.04 |
| April 10, 2024 | 30.57 |
| April 09, 2024 | 29.95 |
| April 08, 2024 | 29.76 |
| April 05, 2024 | 29.76 |
| April 04, 2024 | 27.89 |
| April 03, 2024 | 27.89 |
| April 02, 2024 | 27.60 |
| April 01, 2024 | 27.83 |
| March 31, 2024 | |
| March 28, 2024 | 13.96 |
| March 27, 2024 | 14.00 |
| March 26, 2024 | 13.59 |
| March 25, 2024 | 13.58 |
| March 22, 2024 | 13.71 |
| March 21, 2024 | 13.95 |
| March 20, 2024 | 14.05 |
| March 19, 2024 | 14.05 |
| March 18, 2024 | 13.93 |
| March 15, 2024 | 14.16 |
| March 14, 2024 | 13.95 |
| March 13, 2024 | 14.51 |
| March 12, 2024 | 14.25 |
| March 11, 2024 | 14.50 |
| March 08, 2024 | 15.11 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.866
Minimum
Nov 15 2019
127.36
Maximum
Dec 27 2023
12.93
Average
6.676
Median
Jun 12 2020
Price to Book Value Benchmarks
| Corcept Therapeutics Inc | 5.234 |
| Madrigal Pharmaceuticals Inc | 5.440 |
| Sarepta Therapeutics Inc | 13.05 |
| FibroGen Inc | -- |
| Rocket Pharmaceuticals Inc | 4.812 |
Price to Book Value Related Metrics
| PS Ratio | 7.415 |
| Price | 42.61 |
| Earnings Yield | -18.85% |
| Market Cap | 3.542B |